ReMission Foundation Selects its 2025 Recipient

For 2025, ReMission Foundation, with the support of Weill Cornell Medicine/NewYork-Presbyterian Hospital, is pleased to support Alana Nguyen MD PhD, Assistant Professor in the Division of Hematology and Oncology and her innovative research enhancing anti-tumor immunity in peritoneal metastatic cancer. This research aims to evaluate the role of intraperitoneal administration of dual checkpoint inhibitors in GI malignancies with peritoneal carcinomatosis and ultimately reduce the disease burden and ascites compared to untreated control.

One in three patients with metastatic GI cancer develops peritoneal metastases due to the

high propensity for early metastatic progression of the primary tumor. The incidence of peritoneal metastases varies between the primary tumor sites of GI cancers; the most prevalent GI malignancies to acquire peritoneal metastases are gastric and colon cancers, accounting for 14% of all gastric and 7% of all colon cancer cases, respectively. Dr. Nguyen and her team aim to improve clinical outcomes for patients with GI cancers.

To learn more about Dr. Nguyen's efforts to battle GI, please visit our Annual Cause page here.